Actively Recruiting
Using OCT Angiography to Measure Blood Flow in Rare Retinal and Choroidal Diseases
Led by Oregon Health and Science University · Updated on 2024-02-12
150
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the total blood flow in the retina and choroid, parts of the eye, using advanced imaging techniques called Doppler optical coherence tomography OCT and OCT angiography. The study aims to determine if rare diseases affecting these eye structures change blood flow compared to healthy eyes and whether areas of altered blood flow correspond with damage seen on conventional tests. This research focuses on rare retinal and choroidal diseases to improve understanding of these conditions. The study involves up to 150 patients diagnosed with a rare retinal or choroidal disease. Participants will undergo imaging with functional OCT, including Doppler OCT and OCT angiography, which are non-contact methods that provide detailed, real-time images of eye tissue and blood vessels. These techniques may provide important diagnostic information and could reduce the need for more invasive tests like fluorescein angiography. Participants will be assessed at enrollment and monitored over one year, with evaluations including OCT scans to measure retinal and choroidal blood flow. Researchers will review the total blood flow as the primary outcome. The study excludes those unable to complete tests within 30 days or with conditions affecting image quality or safety. Safety monitoring and informed consent are part of the process, and the total participation duration aligns with the one-year follow-up.
CONDITIONS
Brief Title
OCT in Rare Chorioretinal Diseases
Research Team
K
Kevin Lathrop
D
Denny Romfh, OD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here